Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1691-1700 of 2862 for cancer

Edit search filters
  1. Study Of SC-003 In Subjects With Platinum-Resistant/Refractory Ovarian Cancer

    Rochester, MN

  2. A Study Of Tazemetostat In Treating Patients With Recurrent Ovarian, Primary Peritoneal, Or Endometrial Cancer

    Rochester, MN

  3. Taselisib And Enzalutamide In Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer

    Rochester, MN

  4. Anetumab Ravtansine And Atezolizumab In Treating Participants With Advanced Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study To Evaluate Exemestane In Post-Menopausal Women With Non-Small Cell Lung Cancer (NSCLC)

    Albert Lea, MN, Mankato, MN

  6. A Study Of Rucaparib In Patients With Pancreatic Cancer And A Known Deleterious BRCA Mutation

    Rochester, MN

  7. Linsitinib Or Topotecan Hydrochloride In Treating Patients With Relapsed Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  8. Intravesical Administration Of INSTILADRIN (RAd-IFN With Syn3) In Patients With Bladder Cancer

    Rochester, MN

  9. A Study Of Selpercatinib To Treat Participants With RET-Mutant Medullary Thyroid Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Study Of Imprime PGG And Pembrolizumab In Advanced Melanoma And Triple Negative Breast Cancer

    Rochester, MN

.

Mayo Clinic Footer